Ipilimumab plus nivolumab and chemoradiotherapy followed by surgery in patients with resectable and borderline resectable T3-4N0–1 non-small cell lung cancer: the INCREASE trial

Overview of attention for article published in BMC Cancer, August 2020

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 1 X user

facebook: 1 Facebook page

Citations

dimensions_citation: 27 Dimensions

Readers on

mendeley: 41 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

ALCASE Italia - Per la Lotta al Cancro del Polmone, 27 Aug 2020

Di tutto, di più!!... Come commentare diversamente questo studio olandese che, guarda caso, gli autori hanno chiamato "INCREASE"…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.